Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Sunshine Biopharma (SBFM) over the last 4 years, with Q3 2025 value amounting to 0.24%.

  • Sunshine Biopharma's Return on Invested Capital fell 300.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.25% for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Sunshine Biopharma's Return on Invested Capital stood at 0.24%, which was down 300.0% from 0.26% recorded in Q2 2025.
  • Sunshine Biopharma's Return on Invested Capital's 5-year high stood at 0.19% during Q2 2024, with a 5-year trough of 1.36% in Q1 2023.
  • Its 4-year average for Return on Invested Capital is 0.55%, with a median of 0.24% in 2023.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 11500bps in 2024, then tumbled by -700bps in 2025.
  • Over the past 4 years, Sunshine Biopharma's Return on Invested Capital (Quarter) stood at 0.88% in 2022, then soared by 72bps to 0.24% in 2023, then rose by 7bps to 0.23% in 2024, then dropped by -5bps to 0.24% in 2025.
  • Its Return on Invested Capital was 0.24% in Q3 2025, compared to 0.26% in Q2 2025 and 0.23% in Q1 2025.